Skip to content

Application of Neuro-electrostimulation as a Treatment for Patients With Dry Mouth

Application of Neuro-electrostimulation as a Treatment for Patients With Dry Mouth

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07593495
Enrollment
35
Registered
2026-05-18
Start date
2026-02-01
Completion date
2027-07-31
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Saliva Altered

Keywords

Saliva, Salivation, Xerostomia, Quality of life, Physical Therapy Modalities

Brief summary

Hyposalivation is a condition that has increased in frequency, primarily due to the degeneration of salivary glands caused by aging, polypharmacy, chronic or autoimmune diseases, or radiation treatments. Most of these factors are associated with the elderly, a growing demographic due to the aging population. Therefore, addressing this condition has become crucial in our population, as has understanding how it affects their quality of life. Given that saliva plays a vital role in maintaining the oral mucosa, tooth structure, initiating digestion, and even speech, a long-term treatment to stimulate salivary production would be extremely helpful in resolving these problems. Currently, only palliative measures that temporarily cover or lubricate the oral cavity and its structures are available. Among the most innovative treatments is neuroelectrical stimulation (TENS) as an adjunct in the therapy of dry mouth, which has shown improvement; however, this improvement has not been quantified through objective measurements that would allow for determining the quantity and quality of saliva, nor in the long term. Likewise, the patient's quality of life affected by this condition has not been assessed. Therefore, the objective of this project is to evaluate the effect on salivary quality and quantity after the application of neuroelectrical stimulation as a treatment for patients with dry mouth, as well as their quality of life.

Detailed description

Participants: Patients attending the Orocentro Clinic of the Faculty of Dentistry at the Autonomous University of the State of Mexico with dry mouth symptoms who, upon diagnosis, present with hyposalivation, and who provide their consent and assent to participate in the study. Sampling: Non-probabilistic, quota and convenience sampling. Procedure A clinical examination will be performed to identify patients with dry mouth for confirmatory diagnosis and collection of clinical data. If necessary, a biopsy will be taken to identify Sjögren's disease. After obtaining informed consent and assent, baseline salivary samples will be taken for comparison after neuroelectrostimulation treatment. The Xerostomia Quality of Life Questionnaire will also be administered to assess any changes in quality of life following treatment. To evaluate oral moisture, the time it takes for saliva droplets to form on the inner surface of the buccal mucosa of the lower lip will be measured; this should be less than 60 seconds. Subsequently, the stimulated saliva will be collected by instructing the patient to chew paraffin gum for 5 minutes and then pour all the saliva produced into a calibrated cup. Saliva samples will be collected between 10 and 11 a.m. on study days to standardize the effect of circadian rhythms on salivary parameter assessment. All participants will be instructed to refrain from chewing gum or candy, eating, drinking any liquids or alcohol, smoking, or brushing their teeth for approximately two hours prior to sample collection. Salivary pH and buffering capacity will be evaluated using reagent strips (Saliva-Check Buffer (GC, Alsip, IL, USA)) by immersing them in the stimulated saliva sample. The value will be assigned by colorimetric comparison with the manufacturer's chart. Saliva viscosity will be visually determined. Photographic records of the measurements will be taken to clarify any doubts in their interpretation. After determining the salivary values, and if the participant requests and accepts it, neuro-electrostimulation will be applied. This application will be performed using self-adhesive electrodes (Theratrode or Physiotrode). Before placing the electrodes, the skin area corresponding to the parotid and submandibular glands will be cleaned. The electrodes will be placed bilaterally in this area, and the BTL device will be programmed to TENS current mode with parameters of 4 Hz and a wavelength of 250 µs. The intensity will be adjusted until a visible contraction of the facial muscles is achieved and the patient tolerates it. The Sialometry will be obtained before and after therapy. TENS will be applied twice a week for three weeks. If no changes are seen, the therapy will be changed to magnetic fields. Participants will be followed up at 6 months, during which maintenance therapy will be carried out, and again 1 year after the application of the first therapy. Quality of life and identification of oral lesions will be assessed at two time points (before and at the end of the study). This therapy may vary depending on the severity of the case (hyposalivation/Sjögren's syndrome). Many of these patients require tooth extractions due to dental demineralization and loss of healthy supporting tissues. In these cases, the demineralization of the extracted tooth caused by the lack of mineral content provided by saliva will be evaluated through Vickers microhardness and Diagnodent measurements. Statistical analysis The results will be subjected to the SPSS statistical package, version 26, obtaining descriptive statistics and checking the normality of the corresponding samples, in order to apply the Student's T test for paired samples, ANOVA of repeated measures and Pearson correlation to relate sociodemographic data, with a p-value≤0.05 to find statistically significant differences.

Interventions

DEVICEelectrotherapy and physical therapy device

Previous studies have evaluated the impact of TENS on improving salivary hypofunction, mentioning that placing the device on the parotid gland stimulates the postganglionic efferent fibers of the auriculotemporal nerve, improving the secretomotor impulse of the parotid gland.

Sponsors

Universidad Autonoma del Estado de Mexico
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Salivary values will be determined, and subsequently, neuro-electrostimulation will be performed with self-adhering electrodes at the level of the bilateral parotid and submandibular glands; the BTL equipment will be programmed in TENS current type and the parameters of 4Hz and 250µs wave width will be set and the intensity will be adjusted until there is a visible contraction of the facial muscles and the patient's tolerance. The number of therapies will be modified as the study progresses and the patient's response to the therapy evolves, starting with 6 therapies, applying 2 per week. If there is no good response, magnetic fields will be applied to the patient as a second treatment option.

Eligibility

Sex/Gender
ALL
Age
12 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients diagnosed with dry mouth symptoms. * Patients who wish to participate in the study. * Patients who allow saliva samples to be collected before, during, and after treatment. * Patients who allow the application of transcutaneous electrical nerve stimulation (TENS). * Patients who do not have any active oral infections. * Patients who attend all sialometry assessments and physiotherapy sessions and complete both quality of life questionnaires (initial and final).

Exclusion criteria

* Patients with any other mucosal alteration. * Patients who do not wish to participate in the study. * Patients who do not allow the collection of saliva samples. * Patients who do not allow the application of transcutaneous electrical nerve stimulation (TENS). * Patients with any infectious process in the oral cavity. * Because the study requires the use of low-frequency pulse currents, participants with pacemakers, defibrillators, hearing aids, or cochlear implants will also be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Salivary flow rate (mL/min)one yearChange in salivary flow rate (mL/min), from baseline to after the application of 6 neuro-electro-stimulation therapies or magnetic fields according to the branch of the study. Evaluation after 6 months and up to 1 year.
Salivary pHone yearSalivary pH will be measured to assess salivary acidity from baseline to after the application of 6 neuro-electro-stimulation therapies or magnetic fields according to the branch of the study. Evaluation after 6 months and up to 1 year.
Buffer capacity of salivaone yearChange in buffer capacity saliva from baseline to after the application of 6 neuro-electro-stimulation therapies or magnetic fields according to the branch of the study. Evaluation after 6 months and up to 1 year.

Secondary

MeasureTime frameDescription
Change in health-related quality of lifeOne monthChange in health-related quality of life measured by the Xerostomia Quality of Life Questionnaire (XeQoLS) from baseline to 4 weeks after physiotherapy treatment.

Countries

Mexico

Contacts

CONTACTEdith Lara-Carrillo, PhD
elarac@uaemex.mx+527222126464
CONTACTVíctor Hugo Toral-Rizo, PhD
vhtoralr@uaemex.mx+525540759303
PRINCIPAL_INVESTIGATOREdith Lara-Carrillo, PhD

Professor, School of Dentistry, Autonomous University of the State of Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 19, 2026